Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
11.71
+0.41 (3.63%)
At close: Jan 22, 2026, 4:00 PM EST
11.60
-0.11 (-0.94%)
After-hours: Jan 22, 2026, 5:24 PM EST
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $419.94 million as of January 22, 2026. Its market cap has decreased by -35.22% in one year.
Market Cap
419.94M
Enterprise Value
150.16M
1-Year Change
-35.22%
Ranking
Category
Stock Price
$11.71
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $419.94M, an increase of 67.30%. That is a compound annual growth rate of 12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 405.24M | 9.92% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 434.43M |
| DiaMedica Therapeutics | 427.02M |
| Assembly Biosciences | 416.78M |
| vTv Therapeutics | 415.64M |
| Zura Bio | 410.95M |
| Benitec Biopharma | 410.41M |
| Immutep | 408.62M |
| Lineage Cell Therapeutics | 402.26M |